Sandoz Group AG (SDZNY)

OTCMKTS · Delayed Price · Currency is USD
85.28
+0.81 (0.96%)
Mar 4, 2026, 3:59 PM EST
93.20%
Market Cap 36.82B
Revenue (ttm) 11.16B
Net Income (ttm) 914.00M
Shares Out n/a
EPS (ttm) 2.09
PE Ratio 40.28
Forward PE 20.96
Dividend 0.57 (0.65%)
Ex-Dividend Date Apr 22, 2025
Volume 55,400
Average Volume 52,414
Open 84.94
Previous Close 84.47
Day's Range 84.46 - 85.34
52-Week Range 35.61 - 94.15
Beta 0.26
RSI 53.20
Earnings Date Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Sector Healthcare
Founded 1886
Employees 20,000
Stock Exchange OTCMKTS
Ticker Symbol SDZNY
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.